SU1563707A1 - Method of treating purulent septic disease - Google Patents
Method of treating purulent septic disease Download PDFInfo
- Publication number
- SU1563707A1 SU1563707A1 SU884370705A SU4370705A SU1563707A1 SU 1563707 A1 SU1563707 A1 SU 1563707A1 SU 884370705 A SU884370705 A SU 884370705A SU 4370705 A SU4370705 A SU 4370705A SU 1563707 A1 SU1563707 A1 SU 1563707A1
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- light
- reduce
- treatment
- intracorporeal
- distal end
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title claims description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims description 4
- 238000000034 method Methods 0.000 title description 3
- 238000011282 treatment Methods 0.000 claims abstract description 7
- 239000007788 liquid Substances 0.000 claims abstract description 4
- 210000001124 body fluid Anatomy 0.000 claims abstract description 3
- 239000010839 body fluid Substances 0.000 claims abstract description 3
- 238000010790 dilution Methods 0.000 claims abstract 2
- 239000012895 dilution Substances 0.000 claims abstract 2
- 230000001678 irradiating effect Effects 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 2
- 238000001356 surgical procedure Methods 0.000 abstract description 2
- 239000012530 fluid Substances 0.000 abstract 2
- 238000007865 diluting Methods 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 231100000225 lethality Toxicity 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000000835 fiber Substances 0.000 description 2
- 240000006240 Linum usitatissimum Species 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 201000009906 Meningitis Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
Landscapes
- External Artificial Organs (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
Изобретение относитс к хирургии. Цель - сокращение сроков лечени и снижение летальности, дл чего при интракорпоральном облучении УФ-светом жидкой среды организма производ т дополнительное непрерывное локальное разбавление естественной жидкой среды организма у дистального конца световода оптически прозрачной жидкостью. При этом в качестве разбавл ющей жидкости используют лекарственные средства, дополнительно стерилизующиес при воздействии на них УФ-света. Это позвол ет сократить срок лечени на 2-8 дней, а летальность снизить на 8%.The invention relates to surgery. The goal is to reduce treatment time and reduce lethality, for which, when intracorporeal irradiation with UV light of the body fluid, an additional continuous local dilution of the body's natural fluid medium at the distal end of the light guide with an optically transparent fluid is performed. At the same time, drugs that are additionally sterilized when exposed to UV light are used as the diluting liquid. This reduces the duration of treatment by 2-8 days and reduces mortality by 8%.
Description
Изобретение относитс к медицине, в частности к хирургии трансфузиоло- гии, и может быть использовано при лечении гнойно-септических, сердечно-сосудистых и других заболеваний, при которых положительно сказываетс УФ-об- лучение крови, лимфы или других жидкостей организма.The invention relates to medicine, in particular to surgery for transfusion, and can be used in the treatment of purulent-septic, cardiovascular and other diseases in which UV-radiation of blood, lymph or other body fluids has a positive effect.
Цель изобретени - сокращение сроков лечени и снижение летальности.The purpose of the invention is to reduce the duration of treatment and reduce mortality.
Способ осуществл ют следующим о б- разом.The method is carried out as follows.
Оптически прозрачную жидкость подают в полость между волокном и стенкой катетера. При выходе из катетера она омывает дистальный конец световода , локально разбавл ет естественную среду организма и облучаетс потоком УФ света.Optically transparent liquid is fed into the cavity between the fiber and the wall of the catheter. When exiting the catheter, it washes the distal end of the fiber, locally dilutes the body's natural environment and is irradiated with a stream of UV light.
П р и м е р. Больной, 57 лет диагноз - гнойный менингит о Несмотр на проводимую комплексную интенсивную терапию, включающую экстракорпоральное УФ-облучение аутокрови, состо ние больного оставалось крайне т желым без заметной положительной динамики--, Проведенное интракорпоральное облучение крови УФ-светом с одновременным введением физиологического раствора через катетер в зону облучени в течение 30 мин со скоростью 30 капель в 1 мин обусловило положительную динамику течени заболевани , в результате чего через 3 сут больной был переведен в профильное отделение в компенсированном состо нии.PRI me R. Patient, 57 years old, diagnosed with purulent meningitis. Despite the ongoing comprehensive intensive therapy, including extracorporeal UV irradiation of autologous blood, the patient's condition remained extremely heavy without noticeable positive dynamics. The intracorporeal irradiation of blood with UV light with simultaneous introduction of saline a catheter into the irradiation zone for 30 minutes at a speed of 30 drops in 1 minute caused a positive dynamics of the course of the disease, as a result, after 3 days the patient was transferred to a professional Flax separation in the compensated state.
Предлагаемый способ позвол ет сократить срок лечени на 2 - 3 дн , а летальность снизить на 8%.The proposed method reduces the treatment time by 2 to 3 days, and the mortality rate is reduced by 8%.
сд оFrom to
&э& e
3156370731563707
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SU884370705A SU1563707A1 (en) | 1988-01-26 | 1988-01-26 | Method of treating purulent septic disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SU884370705A SU1563707A1 (en) | 1988-01-26 | 1988-01-26 | Method of treating purulent septic disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SU1563707A1 true SU1563707A1 (en) | 1990-05-15 |
Family
ID=21352533
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU884370705A SU1563707A1 (en) | 1988-01-26 | 1988-01-26 | Method of treating purulent septic disease |
Country Status (1)
| Country | Link |
|---|---|
| SU (1) | SU1563707A1 (en) |
-
1988
- 1988-01-26 SU SU884370705A patent/SU1563707A1/en active
Non-Patent Citations (1)
| Title |
|---|
| Омиров Р. Ю. и др. Внутривенна лазерна гемотерапи в комплексном лечении хирургического сепсиса. - Те-1 зисы докл. на 31-ом Всесоюзном съезде хирургов, г. Ташкент, 1986, с. 192 - 193. * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0126152B1 (en) | A method of treatment of atherosclerosis & a balloon catheter for same | |
| Drinker et al. | A method for maintaining an artificial circulation through the tibia of the dog, with a demonstration of the vasomotor control of the marrow vessels | |
| RU2297861C1 (en) | Method for carrying out transluminal laser-induced brain revascularization in atherosclerotic injury cases | |
| RU2118177C1 (en) | Method of inducing immune response of body | |
| SU1563707A1 (en) | Method of treating purulent septic disease | |
| RU2356587C1 (en) | Therapy of secondary lower limb lymphodema | |
| RU2565656C2 (en) | Body detoxification method and device | |
| RU2093216C1 (en) | Method for treatment of blood | |
| SU1122323A1 (en) | Method of treatment of osteomyelitis | |
| RU2210392C2 (en) | Method for surgical treatment in patients with purulent-septic states | |
| RU2174419C2 (en) | Method for treating patients suffering from acute phlebothrombosis | |
| RU2470600C1 (en) | Method of treating purulent cholangitis | |
| RU2085230C1 (en) | Method of prophylaxis of bleeding and light conductor fixation in the procedure of intravenous laser irradiation of blood | |
| RU2146883C1 (en) | Method for treating the cases of acute obturated cholecystitis | |
| SU1289479A1 (en) | Method of treatment of spasm of accomodation and weak degree of myopia of children | |
| SU1183079A1 (en) | Method of treatment of maxillary sinusitis | |
| RU2119361C1 (en) | Method for treatment of blood vessels diseases | |
| RU2078595C1 (en) | Method for treatment of hepatic insufficiency | |
| RU2167688C2 (en) | Lymphogenous detoxication method | |
| RU2228531C2 (en) | Method for applying therapeutic treatment to organism | |
| RU2262963C1 (en) | Method for optimizing therapy of alcoholic abstinence syndrome | |
| RU2141857C1 (en) | Method for treating glomerulonephritis | |
| RU2014816C1 (en) | Method of treating suppurative maxillary sinusitis | |
| RU2148424C1 (en) | Method for treating frontal and maxillary sinus diseases | |
| RU2005430C1 (en) | Method for treating osteomyelitis of lower extremities |